Cognitive and Behavioral Determinants of Psychotic Symptoms in Alzheimer's Disease

被引:14
|
作者
Quaranta, Davide [1 ]
Vita, Maria Gabriella [1 ]
Bizzarro, Alessandra [1 ]
Masullo, Carlo [1 ]
Piccininni, Chiara [1 ]
Gainotti, Guido [1 ]
Marra, Camillo [1 ]
机构
[1] Catholic Univ, Inst Neurol, Res Ctr Neuropsychol, IT-00168 Rome, Italy
关键词
Alzheimer's disease; Psychosis; Delusions; Delusional misidentifications; Hallucinations; Neuropsychological assessment; PSYCHIATRIC PHENOMENA; NORMATIVE DATA; RISK-FACTORS; DEMENTIA; DISORDERS; DELUSIONS; PSYCHOPATHOLOGY; HALLUCINATIONS; ASSOCIATION;
D O I
10.1159/000369161
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Aims: To investigate the relationship between psychotic symptoms and cognitive impairment in Alzheimer's disease (AD). Methods: A total of 108 subjects affected by AD were subdivided into subjects without delusions (ND), subjects with paranoid delusions (PD), subjects with delusional misidentifications (DM), subjects with both DM and PD (DM+ PD), subjects with visual hallucinations (v-HALL), and subjects without visual hallucinations (N-HALL). Results: PD and ND subjects performed similarly on neuropsychological tests, while DM patients performed significantly worse than PD and ND patients. v-HALL patients performed worse than N-HALL patients on memory, visuospatial, and executive functions. As for behavioral features, DM and v-HALL subjects reported higher scores on the abnormal motor behavior subscale of the neuropsychiatric inventory (NPI); PD subjects reported higher scores on the disinhibition subscale of the NPI. The severity of PD was predicted by the severity of disinhibition (B = 0.514; p = 0.016) but not by neuropsychological performances. The severity of DM was predicted by age (B = 0.099; p = 0.048) and MMSE (B = -0.233; p = 0.001). The severity of v-HALL was predicted by age (B = 0.052; p = 0.037) and scores on an immediate visual memory task (B = -0.135; p = 0.007). Conclusions: The occurrence of PD may require the relative sparing of cognitive functions and be favored by frontal lobe dysfunction, while DM is associated with the overall level of cognitive impairment. Finally, v-HALL are associated with the impairment of visuospatial abilities. (C) 2015 S. Karger AG, Basel
引用
收藏
页码:194 / 206
页数:13
相关论文
共 50 条
  • [1] SPECIFIC COGNITIVE AND BEHAVIORAL DETERMINANTS SUPPORT DIFFERENT PSYCHOTIC SYMPTOMS IN ALZHEIMER'S DISEASE
    Quaranta, D.
    Marra, C.
    Masullo, C.
    Bizzarro, A.
    Vita, M. G.
    Gainotti, G.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 73 - 73
  • [2] Risperidone in the treatment of psychotic, affective and behavioral symptoms associated to Alzheimer's disease
    Barcia, D
    Giles, E
    Herraiz, M
    Moríñigo, A
    Roca, M
    Rodríguez, A
    [J]. ACTAS ESPANOLAS DE PSIQUIATRIA, 1999, 27 (03): : 185 - 190
  • [3] Olanzapine reduces psychotic symptoms and behavioral disturbances associated with Alzheimer's disease
    Street, J
    Clark, WS
    Gannon, KS
    Mitan, S
    Sanger, T
    Tollefson, GD
    [J]. SCHIZOPHRENIA RESEARCH, 2000, 41 (01) : 191 - 191
  • [4] Neurobehaviors and psychotic symptoms in Alzheimer's disease
    Paulsen, JS
    Ready, RE
    Stout, JC
    Salmon, DP
    Thal, LJ
    Grant, I
    Jeste, DV
    [J]. JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2000, 6 (07) : 815 - 820
  • [5] The benefits of memantine treatment on behavioral and psychotic symptoms in mild to moderate Alzheimer's disease
    Ladea, M.
    Sinca, M. C.
    Bran, M.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 138 - 138
  • [6] Efficacy of Rivastigmine on cognitive and behavioral symptoms in patients with Alzheimer's disease
    Baloescu, A
    Tudor, C
    Vasile, D
    Ciurea, R
    Gheorghe, MD
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S58 - S58
  • [7] Involvement of the Serotonergic System in Cognitive and Behavioral Symptoms of Alzheimer's Disease
    Javier Ramirez, Maria
    Aisa, Barbara
    Garcia-Alloza, Monica
    Javier Gil-Bea, Francisco
    Marcos, Beatriz
    [J]. CURRENT PSYCHIATRY REVIEWS, 2005, 1 (03) : 337 - 343
  • [8] Imaging and Neuropsychological Correlates of Cognitive and Behavioral Symptoms in Alzheimer's Disease
    Lippa, Carol F.
    [J]. AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2014, 29 (02): : 109 - 110
  • [9] Selegiline in treatment of behavioral and cognitive symptoms of Alzheimer disease
    Tolbert, SR
    Fuller, MA
    [J]. ANNALS OF PHARMACOTHERAPY, 1996, 30 (10) : 1122 - 1129
  • [10] Cerebral dysfunction and psychotic symptoms in Alzheimer's disease
    Toone, B
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2000, 69 (02): : 148 - 149